Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

The Associated Press May 31, 2012, 10:27AM ET

Johnson & Johnson seeks approval of diabetes pill

Johnson & Johnson said Thursday it filed for marketing approval to the Food and Drug Administration of its drug canagliflozin, a once-per-day pill intended to treat Type 2 diabetes.

Canagliflozin is one of Johnson & Johnson's most promising drug candidates. The company's Janssen division has the right to market the drug in North and South America, Europe, the Middle East, Africa, Australia, New Zealand, and some Asian countries.

Shares of Johnson & Johnson rose 35 cents to $62.56 in morning trading.

BW Mall - Sponsored Links

Buy a link now!